Package 43598-656-05

{"route": ["ORAL"], "spl_id": "dc27d1dd-5931-08dc-e053-2995a90a21f0", "openfda": {"upc": ["0343598655307", "0343598656304", "0343598656908", "0343598655901", "0343598656052", "0343598655055"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["d5469d64-5e74-4b7a-b4cd-551665f6adaa"], "manufacturer_name": ["Dr Reddys Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-656-05)", "package_ndc": "43598-656-05", "marketing_start_date": "20170412"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-656-30)", "package_ndc": "43598-656-30", "marketing_start_date": "20170412"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-656-90)", "package_ndc": "43598-656-90", "marketing_start_date": "20170412"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "43598-656_dc27d1dd-5931-08dc-e053-2995a90a21f0", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "43598-656", "generic_name": "bupropion hydrochloride", "labeler_name": "Dr Reddys Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA207479", "marketing_category": "ANDA", "marketing_start_date": "20170412", "listing_expiration_date": "20261231"}